Sensitive ASX Announcement

Actinogen enhances XanaMIA Phase 2b Alzheimers trial

Published: 26/09/23, 09:46am (AEST)3 pages
Actinogen Medical Limited
ACW:ASXHealthcare

Recent ACW Announcements

Price Sensitive only